Marco Battaglini
Overview
Explore the profile of Marco Battaglini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
2459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barrantes-Cepas M, Noteboom S, Colato E, Battaglini M, Sormani M, De Stefano N, et al.
Mult Scler
. 2025 Feb;
:13524585251314779.
PMID: 40001278
Background: Treatment with cladribine tablets (CladT) in relapsing-remitting multiple sclerosis (RRMS) reduced global grey matter (GM) atrophy, but the effects on regional GM are unknown. Objectives: This study aimed to...
2.
Nguyen A, Sormani M, Horakova D, Havrdova E, Barnett M, De Stefano N, et al.
Mult Scler Relat Disord
. 2024 Nov;
92():106148.
PMID: 39536619
Background: Few studies on multiple sclerosis (MS) have explored the variability of percentage brain volume change (PBVC) measurements obtained from different clinical MRIs. In a retrospective multicentre cohort study, we...
3.
Manco C, Cortese R, Leoncini M, Plantone D, Gentile G, Luchetti L, et al.
J Neurol Sci
. 2024 Aug;
464:123163.
PMID: 39128160
Background: Vascular mild cognitive impairment (VMCI) is a transitional condition that may evolve into Vascular Dementia(VaD). Hippocampal volume (HV) is suggested as an early marker for VaD, the role of...
4.
Luchetti L, Prados F, Cortese R, Gentile G, Calabrese M, Mortilla M, et al.
Neuroimage
. 2024 Aug;
298:120775.
PMID: 39106936
Spinal cord (SC) atrophy obtained from structural magnetic resonance imaging has gained relevance as an indicator of neurodegeneration in various neurological disorders. The common method to assess SC atrophy is...
5.
Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, et al.
Ann Neurol
. 2024 May;
96(2):276-288.
PMID: 38780377
Objective: To evaluate: (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS);...
6.
Cortese R, Battaglini M, Stromillo M, Luchetti L, Leoncini M, Gentile G, et al.
J Neurol
. 2024 May;
271(8):4897-4908.
PMID: 38743090
Background: Research work has shown that hippocampal subfields are atrophic to varying extents in multiple sclerosis (MS) patients. However, studies examining the functional implications of subfield-specific hippocampal damage in early...
7.
Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, et al.
Ann Neurol
. 2024 Apr;
96(1):1-20.
PMID: 38568026
Clinical, pathological, and imaging evidence in multiple sclerosis (MS) suggests that a smoldering inflammatory activity is present from the earliest stages of the disease and underlies the progression of disability,...
8.
Lazzarotto A, Hamzaoui M, Tonietto M, Dubessy A, Khalil M, Pirpamer L, et al.
Brain
. 2024 Jan;
147(4):1331-1343.
PMID: 38267729
Cortical myelin loss and repair in multiple sclerosis (MS) have been explored in neuropathological studies, but the impact of these processes on neurodegeneration and the irreversible clinical progression of the...
9.
Mattiesing R, Kramer E, Strijbis E, Brouwer I, van Schijndel R, Gentile G, et al.
Mult Scler
. 2023 Nov;
30(1):44-54.
PMID: 38018502
Background: Whether the degree of inflammation (and its resolution) and neurodegeneration after treatment initiation predicts disease progression in multiple sclerosis (MS) remains unclear. Objectives: To assess the predictive value of...
10.
Gentile G, Jenkinson M, Griffanti L, Luchetti L, Leoncini M, Inderyas M, et al.
Hum Brain Mapp
. 2023 Aug;
44(14):4893-4913.
PMID: 37530598
In this work we present BIANCA-MS, a novel tool for brain white matter lesion segmentation in multiple sclerosis (MS), able to generalize across both the wide spectrum of MRI acquisition...